ZHYBF — Zhong Yuan Bio-Technology Holdings Income Statement
0.000.00%
Last trade - 00:00
- $88.22m
- $89.66m
- $1.66m
2019 March 31st | 2020 March 31st | C2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.22 | 1.22 | 1.64 | 2.33 | 1.66 |
Cost of Revenue | |||||
Gross Profit | 0.897 | 0.963 | 1.35 | 1.91 | 1.52 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.902 | 1.31 | 1.65 | 3.01 | 3.44 |
Operating Profit | 0.315 | -0.086 | -0.015 | -0.686 | -1.78 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.296 | -0.087 | -0.028 | -0.672 | -1.76 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.28 | -0.087 | -0.028 | -0.683 | -1.75 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.28 | -0.087 | -0.028 | -1.13 | -2.23 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.28 | -0.087 | -0.028 | -1.13 | -2.23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.016 | -0.005 | -0.002 | -0.04 | -0.077 |